Based on the provided content, here's an analysis of CVE-2020-12035:

**Root Cause of Vulnerability:**

*   The Baxter PrismaFlex and PrisMax devices do not require authentication when configured to send treatment data to a Patient Data Management System (PDMS) or an Electronic Medical Record (EMR) system.

**Weaknesses/Vulnerabilities Present:**

*   **Improper Authentication (CWE-287):** Lack of authentication when sending data to external systems.

**Impact of Exploitation:**

*   An attacker could modify treatment status information.
*   Potential exposure of sensitive patient data (PHI) depending on the nature of the treatment status information.

**Attack Vectors:**

*   **Network-based:** An attacker with network access to the affected device could exploit this vulnerability.

**Required Attacker Capabilities/Position:**

*   **Network Access:** The attacker needs network connectivity to the device.
*   **Low Skill Level:** The advisory notes this vulnerability is exploitable with a low skill level.
*   **User Interaction:** Although the CVSS vector includes UI:R, this refers to a system configuration where the sending of data to a PDMS or EMR is manually triggered. The UI:R does not imply a required interaction by the attacker

**Additional Notes:**

*   This vulnerability is specific to the Baxter PrismaFlex and PrisMax devices when configured to send data to a PDMS or EMR.
*   The advisory provides mitigations, including upgrading the PrisMax to version 3 with DCM, network segmentation, and ensuring proper physical access controls.
*   The advisory also references additional cybersecurity guidance from the FDA and CISA.

This advisory provides more details than a typical CVE description, outlining the affected devices and the impact of the vulnerability